These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32267363)

  • 21. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
    Albiger NM; Regazzo D; Rubin B; Ferrara AM; Rizzati S; Taschin E; Ceccato F; Arnaldi G; Pecori Giraldi F; Stigliano A; Cerquetti L; Grimaldi F; De Menis E; Boscaro M; Iacobone M; Occhi G; Scaroni C
    Endocrine; 2017 Mar; 55(3):959-968. PubMed ID: 27094308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological Harbingers of ARMC5-Pathogenic Variant-Related Bilateral Macronodular Adrenocortical Disease.
    de Arruda Botelho MLA; Nishi MY; Ribeiro KB; Zerbini MCN
    Endocr Pathol; 2023 Jun; 34(2):200-212. PubMed ID: 37043100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia.
    Zhang Q; Cui L; Gao JP; Yan WH; Jin N; Chen K; Zang L; Du J; Wang XL; Guo QH; Yang GQ; Yang LJ; Ba JM; Gu WJ; Lv ZH; Dou JT; Mu YM; Lu JM
    Endocr J; 2018 Mar; 65(3):269-279. PubMed ID: 29279458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.
    Berthon A; Faucz FR; Espiard S; Drougat L; Bertherat J; Stratakis CA
    Hum Mol Genet; 2017 Sep; 26(18):3495-3507. PubMed ID: 28911199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.
    Berthon A; Hannah-Shmouni F; Maria AG; Faucz FR; Stratakis CA
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105316. PubMed ID: 31014964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia.
    Lao L; Bourdeau I; Gagliardi L; He X; Shi W; Hao B; Tan M; Hu Y; Peng J; Coulombe B; Torpy DJ; Scott HS; Lacroix A; Luo H; Wu J
    Nucleic Acids Res; 2022 Jun; 50(11):6343-6367. PubMed ID: 35687106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of primary macronodular adrenal hyperplasia.
    Candida Barisson Villares Fragoso M; Pontes Cavalcante I; Meneses Ferreira A; Marinho de Paula Mariani B; Ferini Pacicco Lotfi C
    Presse Med; 2018; 47(7-8 Pt 2):e139-e149. PubMed ID: 30075949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions.
    Mulatero P; Schiavi F; Williams TA; Monticone S; Barbon G; Opocher G; Fallo F
    J Hum Hypertens; 2016 Jun; 30(6):374-8. PubMed ID: 26446392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Macronodular adrenal hyperplasia causing Cushing's syndrome due to ARMC5 gene mutation.].
    Hella Z; Tőke J; Patócs A; Varga Z; Dabasi G; Kovács GL; Tóth M
    Orv Hetil; 2023 Aug; 164(32):1271-1277. PubMed ID: 37573559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report.
    Liu Q; Tong D; Xu J; Yang X; Yi Y; Zhang D; Wang L; Zhang J; Zhang Y; Li Y; Chang L; Chen R; Guan Y; Yi X; Jiang J
    BMC Med Genet; 2018 Mar; 19(1):49. PubMed ID: 29587644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas.
    Morelli V; Elli FM; Frigerio S; Vena W; Palmieri S; Lucca C; Maffini MA; Contarino A; Bagnaresi F; Mantovani G; Arosio M
    Eur J Endocrinol; 2023 Aug; 189(2):242-251. PubMed ID: 37625448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH).
    Giacché M; Panarotto A; Mori L; Poliani PL; Lanzi R; Lena MS; Castellano M
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2126. PubMed ID: 36727580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Armc5 deletion causes developmental defects and compromises T-cell immune responses.
    Hu Y; Lao L; Mao J; Jin W; Luo H; Charpentier T; Qi S; Peng J; Hu B; Marcinkiewicz MM; Lamarre A; Wu J
    Nat Commun; 2017 Feb; 8():13834. PubMed ID: 28169274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report.
    Jojima T; Kogai T; Iijima T; Kato K; Sagara M; Kezuka A; Kase M; Sakurai S; Akimoto K; Sakumoto J; Namatame T; Ueki K; Hishinuma A; Kamai T; Usui I; Aso Y
    Eur J Endocrinol; 2020 Dec; 183(6):K7-K12. PubMed ID: 33105102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia.
    Gagliardi L; Schreiber AW; Hahn CN; Feng J; Cranston T; Boon H; Hotu C; Oftedal BE; Cutfield R; Adelson DL; Braund WJ; Gordon RD; Rees DA; Grossman AB; Torpy DJ; Scott HS
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1784-92. PubMed ID: 24905064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?
    Emms H; Tsirou I; Cranston T; Tsagarakis S; Grossman AB
    Endocrine; 2016 Sep; 53(3):801-8. PubMed ID: 27306888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors.
    Okuno Y; Fukuhara A; Otsuki M; Shimomura I
    JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35862218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hereditary Cushing's syndrome caused by primary bilateral macronodular adrenal hyperplasia due to ARMC5 mutation with concomitant primary hyperparathyroidism: the first known case in Russia].
    Mamedova EO; Vasilyev EV; Petrov VM; Izmailova NS; Buryakina SA; Rozhinskaya LY; Tiulpakov AN; Belaya ZE
    Probl Endokrinol (Mosk); 2019 Jun; 65(2):89-94. PubMed ID: 31271710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
    Maria AG; Tatsi C; Berthon A; Drougat L; Settas N; Hannah-Shmouni F; Bertherat J; Faucz FR; Stratakis CA
    Endocr Relat Cancer; 2020 Sep; 27(9):509-517. PubMed ID: 32638579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.